The Effect of Beta-blockers in Substance P Levels and the Swallowing Function

• Conditions: Swallowing Disorder; Substance P; Beta Blockers

• Registration Number: NCT03306134
• Lead Sponsor: Hospital de Mataró

Brief Summary

A non-randomised, prospective study to assess the effects of beta-blockers on substance P levels and the swallowing function. The study is going to be carry out in the Gastrointestinal Physiology Laboratory of the Hospital de Mataró (Spain). All participants will be actively recruited from a Linked hospital and primary care database. We include two groups: the first group (group 1) are participants taking beta-blockers and the second group (group 2) are participants not-taking beta-blockers.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-06-05
• Study First Submitted: 2017-09-22
• Study First Submitted QC: 2017-10-07
• Study First Posted: 2017-10-10
• Status Verified: 2018-02
• Last Update Submitted: 2018-02-21
• Last Update Posted: 2018-02-22
• Primary Completion: 2018-11-25
• Study Completion: 2018-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Patients taking and not taking beta-blockers

Exclusion Criteria

• Participants with heat and neck or esophageal cancer
• Participants with stroke or neurological disease
• Participants with central nervous system disease
• Participants with concomitant treatment with Angiotensin converting enzyme inhibitors (ACEI), Angiotensin II receptor antagonists (ARA-II), Antipsychotics, Dopamine agonists, Capsaicine.
• Participants with severe clinical signs of aspiration, including oxygen desaturation ≥3%.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Substance P levels	1 year	In blood and saliva

Trial Locations

Locations (1)

Mataró Hospital; 🇪🇸 Mataró, Barcelona, Spain